⌘K

Login Start Free

Home/Filings/4/0001209191-22-030255

4//SEC Filing

Doyle Ramona 4

Accession 0001209191-22-030255

CIK 0001601830other

View on SEC.gov Company Profile

Filed

May 17, 8:00 PM ET

Accepted

May 18, 7:19 PM ET

Size

4.9 KB

Accession

0001209191-22-030255

Insider Transaction Report

Form 4

Period: 2022-05-16

RECURSION PHARMACEUTICALS, INC.RXRX

Chief Medical Officer

Transactions

Tax Payment
Class A Common Stock
2022-05-16$5.67/sh−832$4,717→ 121,110 total

Footnotes (1)

[F1]Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

RECURSION PHARMACEUTICALS, INC.

CIK 0001601830

Entity typeother

Related Parties

1

filerCIK 0001856069

Filing Metadata

Form type: 4
Filed: May 17, 8:00 PM ET
Accepted: May 18, 7:19 PM ET
Size: 4.9 KB

View on SEC.gov